ClickChina Cultural Exchange Co., Ltd.
60,000 people have been vaccinated against China's new crown vaccine! No serious adverse reaction report received
- Time of issue:2020-11-26 14:25
Tian Baoguo, deputy director of the Department of Science and Technology for Social Development, Ministry of Science and Technology, said that currently 13 vaccines in my country have entered the clinical stage. Among them, two technical routes of inactivated vaccines and adenovirus vector vaccines, a total of 4 vaccines, have entered Phase III clinical trials. Up to now, a total of about 60,000 subjects have been vaccinated.
Phase III clinical trial results are an internationally recognized effectiveness indicator for verifying vaccine-induced protection. According to Tian Baoguo, the new coronavirus vaccine currently entering phase III clinical trials has basically mild adverse reactions, such as local pain at the injection site, pain and swelling at the injection site, and a short period of time. Sexual low-grade fever, fever, etc.
my country's vaccine production capacity may reach 610 million doses by the end of this year
According to Zheng Zhongwei, director of the Science and Technology Development Center of the National Health Commission:
It is estimated that my country's vaccine production capacity will reach 610 million doses by the end of this year. Next year, the annual production capacity of my country's new crown vaccine will be effectively expanded on this basis.
As a global public product, it is given priority to developing countries
China has been actively fulfilling its commitment to make the new crown vaccine a global public product and promote the fair distribution of safe and effective vaccines.
On October 8, China joined the "New Coronary Pneumonia Vaccine Implementation Plan" jointly led by the World Health Organization and its partners to ensure the effective and fair distribution of new coronary pneumonia vaccines on a global scale. As of October 20, 184 countries and regions have joined the plan.
(Reposted from China Daily)
WECHAT PUBLIC ACCOUNT
LEAVE A MESSAGE